The investigational oral orexin 2 receptor agonist received designations from the FDA for idiopathic hypersomnia and the European Commission for narcolepsy.

The collaboration integrates data from the ProSomnus RPMO₂ into MonitAir’s platform to support longitudinal tracking.

Researchers have identified 10 molecular biomarkers in saliva that can detect 24-hour sleep deprivation with 94% accuracy, marking a significant step toward developing noninvasive roadside testing. This breakthrough stud...

BALTIMORE – Today, Dr. Fariha Abbasi-Feinberg became president of the American Academy of Sleep Medicine board of directors. She assumed the role during SLEEP 2026, the 40th annual meeting of the nation’s leading sleep m...

Season 8 | Episode 10 In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. Daniel Buysse and Dr. Todd Arnedt, both members of the AASM clinical practice guideline committee, to discuss the newly released...

A study of 28 million days of health data reveals that fewer than 13% of individuals consistently meet both sleep and physical activity guidelines, suggesting that high-quality sleep is a primary driver of next-day movem...

The consolidation brings together CleveMed’s home sleep testing infrastructure and Beacon’s AI-driven brain monitoring technology to advance at-home sleep diagnostics.

The water-based temperature-control system features a nightstand remote, simplified setup, and US-based engineering, without requiring a subscription.

Hypoxic burden has also been added to the platform for the chest-worn home sleep test.

The new platform integrates Wesper Lab and Wesper Lite to offer customized diagnostic pathways and streamline patient management for sleep clinics.